COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

[1]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[2]  Claudio Pedone,et al.  Comorbidities of chronic obstructive pulmonary disease , 2011, Current opinion in pulmonary medicine.

[3]  P. Jousilahti,et al.  No increase in the prevalence of COPD in two decades , 2010, European Respiratory Journal.

[4]  I. Pavord,et al.  Chronic obstructive pulmonary disease in non-smokers , 2009, The Lancet.

[5]  P. Gold,et al.  The 2007 GOLD Guidelines: a comprehensive care framework. , 2009, Respiratory care.

[6]  Yan Guo,et al.  Does per-diem reimbursement necessarily increase length of stay? The case of a public psychiatric hospital. , 2009, Health economics.

[7]  D. Mannino,et al.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.

[8]  K. Rabe,et al.  Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.

[9]  A. Sheikh,et al.  National survey on the roles and training of primary care respiratory nurses in the UK in 2006: are we making progress? , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.

[10]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[11]  Donna Bergen.  Neurological Disorders: Public Health Challenges , 2007 .

[12]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[13]  J. Dollerup,et al.  The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls. , 2007, Respiratory medicine.

[14]  L. Smeeth,et al.  Standardized training for healthcare professionals and its impact on patients with perennial rhinitis: a multi‐centre randomized controlled trial , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[16]  M. Decramer,et al.  Integrated care prevents hospitalisations for exacerbations in COPD patients , 2006, European Respiratory Journal.

[17]  D. Halpin.  Health economics of chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[18]  A. V. van Keimpema,et al.  Employment and disability for work in patients with COPD: a cross-sectional study among Dutch patients , 2006, International archives of occupational and environmental health.

[19]  T. Jin,et al.  Increased risk of chronic obstructive pulmonary diseases in coke oven workers: interaction between occupational exposure and smoking , 2006, Thorax.

[20]  C. D. Mathers,et al.  Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.

[21]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[22]  P. Jones,et al.  Measuring the effects of COPD on the patient. , 2005, Respiratory medicine.

[23]  D. Halpin,et al.  Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers , 2004, Palliative medicine.

[24]  F Neukirch,et al.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages , 2004, Thorax.

[25]  D. Price,et al.  The pharmacoepidemiology of COPD: Recent advances and methodological discussion , 2003, European Respiratory Journal.

[26]  M. Halpern,et al.  The burden of COPD in the U.S.A.: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[27]  Melanie C. Green,et al.  Telephone versus Face-to-Face Interviewing of National Probability Samples with Long Questionnaires: Comparisons of Respondent Satisficing and Social Desirability Response Bias , 2003 .

[28]  E. Wouters.  Economic analysis of the Confronting COPD survey: an overview of results. , 2003, Respiratory medicine.

[29]  J. Izquierdo,et al.  The burden of COPD in Spain: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[30]  M. Decramer,et al.  Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.

[31]  S. Lareau,et al.  Memory for symptoms in COPD patients: how accurate are their reports? , 2001, The European respiratory journal.

[32]  M P Rutten-van Mölken,et al.  The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. , 2001, American journal of respiratory and critical care medicine.

[33]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[34]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[35]  T. Seemungal,et al.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[36]  P Carlsson,et al.  Resource costing for multinational neurologic clinical trials: methods and results. , 1998, Health economics.

[37]  J. Hutton,et al.  Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients. , 1998, Anti-cancer drugs.

[38]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[39]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[40]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[41]  P. Jones,et al.  Health-related quality of life in patients by COPD severity within primary care in Europe. , 2011, Respiratory medicine.

[42]  P. Montuschi.  Treatment of stable chronic obstructive pulmonary disease Bronchodilators , 2007 .

[43]  J. Bousquet,et al.  Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. , 2007 .

[44]  Jonathan Elford,et al.  BMC Public Health BioMed Central Study protocol , 2006 .

[45]  M. Chan-yeung,et al.  The burden and impact of COPD in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[46]  P. Rautava,et al.  Non-response and related factors in a nation-wide health survey , 2004, European Journal of Epidemiology.

[47]  J. Bourbeau,et al.  The burden of COPD in Canada: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[48]  M Britton,et al.  The burden of COPD in the U.K.: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[49]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[50]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .